The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Habitrol Nicotine Polacrilex Lozenge Mint
Nicotine Polacrilex Lozenge 2 mg · NICOTINE 2 mg/1 · Lozenge · Oral · Dr. Reddy's Laboratories Inc.
NDC 43598-0986-13 · 5 BOTTLE in 1 CARTON / 27 LOZENGE in 1 BOTTLE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- ANDA212796
- TE code
- —
- Approval date
- Jan 8, 2020
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Nicotine Polacrilex Lozenge 2 mg (Lozenge)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Dr. Reddy's Laboratories Inc. | NICOTINE 2 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Chain Drug Marketing Association INC | NICOTINE 2 mg/1 | Jul 15, 2026 | Jul 29, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Habitrol Nicotine Polacrilex Lozenge Mint — NDC 43598-0986-13," retrieved September 3, 2026, https://drugdashboards.com/drug/43598098613.
Free to cite with attribution — see how the data is put together.